Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse.


Journal

Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857

Informations de publication

Date de publication:
05 2021
Historique:
revised: 29 12 2020
received: 10 09 2020
accepted: 26 01 2021
pubmed: 3 2 2021
medline: 25 6 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

Bariatric surgery is common, but alcohol misuse has been reported following these procedures. We aimed to determine if bariatric surgery is associated with increased risk of alcohol-related cirrhosis (AC) and alcohol misuse. Retrospective observational analysis of obese adults with employer-sponsored insurance administrative claims from 2008 to 2016. Subjects with diagnosis codes for bariatric surgery were included. Primary outcome was risk of AC. Secondary outcome was risk of alcohol misuse. Bariatric surgery was divided into before 2008 and after 2008 to account for patients who had a procedure during the study period. Cox proportional hazard regression models using age as the time variable were used with interaction analyses for bariatric surgery and gender. A total of 194 130 had surgery from 2008 to 2016 while 209 090 patients had bariatric surgery prior to 2008. Age was 44.1 years, 61% women and enrolment was 3.7 years. A total of 4774 (0.07%) had AC. Overall risk of AC was lower for those who received sleeve gastrectomy and laparoscopic banding during the study period (HR 0.4, P <.001; HR 0.43, P =.02) and alcohol misuse increased for Roux-en-Y and sleeve gastrectomy recipients (HR 1.86 and 1.35, P <.001, respectively). In those who had surgery before 2008, women had increased risk of AC and alcohol misuse compared to women without bariatric surgery (HR 2.1 [95% CI: 1.79-2.41] for AC; HR 1.98 [95% CI 1.93-2.04]). Bariatric surgery is associated with a short-term decreased risk of AC but potential long-term increased risk of AC in women. Post-operative alcohol surveillance is necessary to reduce this risk.

Sections du résumé

BACKGROUND & AIMS
Bariatric surgery is common, but alcohol misuse has been reported following these procedures. We aimed to determine if bariatric surgery is associated with increased risk of alcohol-related cirrhosis (AC) and alcohol misuse.
METHODS
Retrospective observational analysis of obese adults with employer-sponsored insurance administrative claims from 2008 to 2016. Subjects with diagnosis codes for bariatric surgery were included. Primary outcome was risk of AC. Secondary outcome was risk of alcohol misuse. Bariatric surgery was divided into before 2008 and after 2008 to account for patients who had a procedure during the study period. Cox proportional hazard regression models using age as the time variable were used with interaction analyses for bariatric surgery and gender.
RESULTS
A total of 194 130 had surgery from 2008 to 2016 while 209 090 patients had bariatric surgery prior to 2008. Age was 44.1 years, 61% women and enrolment was 3.7 years. A total of 4774 (0.07%) had AC. Overall risk of AC was lower for those who received sleeve gastrectomy and laparoscopic banding during the study period (HR 0.4, P <.001; HR 0.43, P =.02) and alcohol misuse increased for Roux-en-Y and sleeve gastrectomy recipients (HR 1.86 and 1.35, P <.001, respectively). In those who had surgery before 2008, women had increased risk of AC and alcohol misuse compared to women without bariatric surgery (HR 2.1 [95% CI: 1.79-2.41] for AC; HR 1.98 [95% CI 1.93-2.04]).
CONCLUSIONS
Bariatric surgery is associated with a short-term decreased risk of AC but potential long-term increased risk of AC in women. Post-operative alcohol surveillance is necessary to reduce this risk.

Identifiants

pubmed: 33529460
doi: 10.1111/liv.14805
pmc: PMC8204517
mid: NIHMS1708749
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1012-1019

Subventions

Organisme : NIAAA NIH HHS
ID : K23 AA026333
Pays : United States
Organisme : NIAAA NIH HHS
ID : K23 AA023869
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034933
Pays : United States

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

JAMA Surg. 2013 Apr;148(4):374-7
pubmed: 23716012
Gastroenterol Clin North Am. 2016 Jun;45(2):345-58
pubmed: 27261903
Surg Obes Relat Dis. 2020 Apr;16(4):536-544
pubmed: 32075778
J Am Coll Surg. 2011 Feb;212(2):209-14
pubmed: 21183366
BMJ. 2018 Jul 18;362:k2817
pubmed: 30021785
Surg Endosc. 2019 Aug;33(8):2521-2530
pubmed: 30350107
Hepatology. 1996 May;23(5):1025-9
pubmed: 8621128
Am J Surg. 2006 Nov;192(5):657-62
pubmed: 17071202
Gastroenterology. 2016 Apr;150(4):888-94; quiz e18
pubmed: 26709032
Am J Psychiatry. 2007 Feb;164(2):328-34; quiz 374
pubmed: 17267797
Surg Endosc. 2018 Mar;32(3):1382-1388
pubmed: 28840338
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):253-254
pubmed: 29443115
Compr Psychiatry. 2014 Feb;55(2):248-59
pubmed: 24290079
Arch Gen Psychiatry. 2008 Feb;65(2):172-8
pubmed: 18250255
Drug Alcohol Depend. 2015 Nov 1;156:1-13
pubmed: 26371405
JAMA. 1998 Jul 8;280(2):166-71
pubmed: 9669791
Hepatol Int. 2013 Mar;7(1):280-5
pubmed: 26201643
Hepatology. 2018 Sep;68(3):872-882
pubmed: 29579356
J Am Coll Surg. 2012 Oct;215(4):475-9
pubmed: 22770864
Gen Hosp Psychiatry. 2009 Sep-Oct;31(5):414-21
pubmed: 19703634
Surg Obes Relat Dis. 2013 Nov-Dec;9(6):926-35
pubmed: 23602493
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Addiction. 2015 Dec;110(12):1932-40
pubmed: 26235801
Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6
pubmed: 25917783
Surg Obes Relat Dis. 2013 Mar-Apr;9(2):159-91
pubmed: 23537696
Gastroenterology. 2012 Nov;143(5):1179-1187.e3
pubmed: 22885331
Surg Obes Relat Dis. 2012 May-Jun;8(3):357-63
pubmed: 22425058
JAMA Psychiatry. 2017 Sep 1;74(9):911-923
pubmed: 28793133
Hepatology. 2018 Jun;67(6):2141-2149
pubmed: 29164643
Addict Biol. 2017 Nov;22(6):1540-1553
pubmed: 27578259
Hepatol Res. 2012 Apr;42(4):359-67
pubmed: 22150916
Surg Obes Relat Dis. 2018 Mar;14(3):277-283
pubmed: 29305304
JAMA Intern Med. 2017 Aug 1;177(8):1175-1182
pubmed: 28654959
JAMA Surg. 2015 Nov;150(11):1096-8
pubmed: 26244751
Surg Obes Relat Dis. 2017 Aug;13(8):1392-1402
pubmed: 28528115
N Engl J Med. 2017 Sep 21;377(12):1143-1155
pubmed: 28930514

Auteurs

Jessica L Mellinger (JL)

Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.

Kerby Shedden (K)

Department of Statistics, University of Michigan, Ann Arbor, MI, USA.

G Scott Winder (GS)

Department of Psychiatry, Ann Arbor, MI, USA.

Anne C Fernandez (AC)

Department of Psychiatry, Ann Arbor, MI, USA.

Brian P Lee (BP)

University of California, San Francisco, CA, USA.

Jennifer Waljee (J)

Department of Surgery, University of Michigan, Ann Arbor, MI, USA.

Robert Fontana (R)

Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.

Michael L Volk (ML)

Transplantation Institute, Loma Linda University Health, Loma Linda, CA, USA.

Frederic C Blow (FC)

Department of Psychiatry, Ann Arbor, MI, USA.
VA Center for Clinical Management Research (CCMR), Ann Arbor, MI, USA.

Anna S F Lok (ASF)

Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH